Rilpivirine Dibromo Impurity is a synthetic byproduct arising from bromination during the rilpivirine synthesis pathway. It features a 4,5-dibromo-substituted 2-pyridine ring conjugated to a pyrimidine core via a methylene bridge, with a 2,5-dimethylpyrimidin-4-yl moiety appended to the pyridine. The dibromination introduces steric and electronic perturbations that alter the parent drug's photophysical properties. This impurity serves as a critical HPLC reference standard for quantifying bromination-related deviations in API batches.
On Request